Skip to main navigation Skip to search Skip to main content

Inhaled Medicines for Targeting Non-Small Cell Lung Cancer

  • University of Reading
  • Al Ahliyya Amman University

Research output: Contribution to journal › Review article › peer-review

22 Scopus citations

Abstract

Throughout the years, considerable progress has been made in methods for delivering drugs directly to the lungs, which offers enhanced precision in targeting specific lung regions. Currently, for treatment of lung cancer, the prevalent routes for drug administration are oral and parenteral. These methods, while effective, often come with side effects including hair loss, nausea, vomiting, susceptibility to infections, and bleeding. Direct drug delivery to the lungs presents a range of advantages. Notably, it can significantly reduce or even eliminate these side effects and provide more accurate targeting of malignancies. This approach is especially beneficial for treating conditions like lung cancer and various respiratory diseases. However, the journey towards perfecting inhaled drug delivery systems has not been without its challenges, primarily due to the complex structure and functions of the respiratory tract. This comprehensive review will investigate delivery strategies that target lung cancer, specifically focusing on non-small-cell lung cancer (NSCLC)—a predominant variant of lung cancer. Within the scope of this review, active and passive targeting techniques are covered which highlight the roles of advanced tools like nanoparticles and lipid carriers. Furthermore, this review will shed light on the potential synergies of combining inhalation therapy with other treatment approaches, such as chemotherapy and immunotherapy. The goal is to determine how these combinations might amplify therapeutic results, optimizing patient outcomes and overall well-being.

Original languageEnglish
Article number2777
JournalPharmaceutics
Volume15
Issue number12
DOIs
StatePublished - Dec 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • NSCLC
  • immunotherapy
  • inhalers
  • liposomes
  • nanoparticles
  • passive and active targeting

Fingerprint

Dive into the research topics of 'Inhaled Medicines for Targeting Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this